(Why to use fixed dose perindopril, bisoprolol combination in hypertonics with CHD?)

نویسندگان

چکیده

KardiovaskulĂĄrnĂ­ onemocněnĂ­ jsou celosvětově nejčastějĹĄĂ­ příčinou Ăşmrtnosti. ArteriĂĄlnĂ­ hypertenze patří k ovlivnitelnĂ˝m rizikovĂ˝m faktorĹŻm aterosklerĂłzy a jejĂ­ časnĂĄ léčebnĂĄ intervence vĂ˝znamně sniĹžuje kardiovaskulĂĄrnĂ­ morbiditu mortalitu. Léčbu musĂ­me přizpĹŻsobit jednotlivĂŠmu pacientovi na mĂ­ru dle zĂĄvaĹžnosti jeho kardiovaskulĂĄrnĂ­mu i metabolickĂŠmu rizikovĂŠmu profilu. FixnĂ­ kombinace mĂĄ řadu vĂ˝hod od lepĹĄĂ­ho rychlejĹĄĂ­ho dosaĹženĂ­ cĂ­lovĂ˝ch hodnot krevnĂ­ho tlaku přes menĹĄĂ­ mnoĹžstvĂ­ neŞådoucĂ­ch účinkĹŻ aĹž po zlepĹĄenĂ­ adherence léčbě. Kombinace beta-blokĂĄtoru (bisoprololu) inhibitoru angiotenzin konvertujĂ­cĂ­ho enzymu (perindoprilu) komplementĂĄrnĂ­ účinky sympatickĂ˝ nervovĂ˝ systĂŠm osu renin-angiotenzin-aldosteron. těchto lĂŠkĹŻ účinně krevnĂ­ tlak tepovou frekvenci, coĹž zlepĹĄuje prognĂłzu vybranĂ˝ch nemocnĂ˝ch. ČlĂĄnek je věnovĂĄn indikacĂ­m u pacientĹŻ jak v léčbě nekomplikovanĂŠ hypertenze, tak sekundĂĄrnĂ­ prevenci s ischemickou chorobou srdečnĂ­. DĹŻraz kladen zejmĂŠna postavenĂ­ beta-blokĂĄtorĹŻ. © 2023, ČKS.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients.

BACKGROUND The effect on endothelium-dependent and independent vasodilation of 24-week treatment with a fixed-dose combination of perindopril/indapamide (2/0.625 mg, daily) and atenolol (50 mg, daily), was evaluated in 62 untreated essential hypertensive patients according a double-blind, parallel group, randomized study. METHODS Brachial artery flow-mediated dilation (FMD), response to subli...

متن کامل

Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study

10.2217/14750708.4.5.677 © 2 PRETEND was a multicenter observational survey carried out in primary-care clinics across Spain. It was designed to determine general practitioners’ perceptions regarding their clinical experience with the fixed low-dose combination of perindopril 2 mg plus indapamide 0.625 mg in everyday practice. A total of 3198 patients, mean age 62.4 ± 10.9 years, were included....

متن کامل

Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study

INTRODUCTION We conducted a prospective, non-interventional, multicenter study to examine the effect of a fixed-dose combination of perindopril/amlodipine in patients with arterial hypertension. METHODS Patients who were previously untreated or required a change in medication were treated with a fixed combination of perindopril/amlodipine (3.5/2.5 or 7.0/5.0 mg) for 12 weeks. Changes in offic...

متن کامل

Fixed-dose combination Therapy in Hypertension: Focus on Fixed-dose combination of Amlodipine and Valsartan (exforge®)

Hypertension is the leading cause of disability and cardiovascular mortality world-wide. Approximately one-third of the US adult population and over a billion people world-wide have hypertension. Despite increased awareness of hypertension and availability of many effective antihypertensive agents, only one third of patients achieve their target blood pressure (BP). All expert panels now recomm...

متن کامل

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial

BACKGROUND Hypertension and type 2 diabetes mellitus (T2DM) synergistically deteriorate the vascular environment, making blood pressure reduction challenging, and substantially increasing cardiovascular risk. METHODS In the real-life, open-label, observational, PICASSO study, 9,257 hypertensive patients unsuccessfully treated with antihypertensives were switched to fixed-dose combination of p...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cor et vasa

سال: 2023

ISSN: ['0010-8650', '1803-7712']

DOI: https://doi.org/10.33678/cor.2023.004